Indraprastha Medical Corporation Limited share price

NSE: INDRAMEDCO · ISIN INE681B01017

Key numbers

Market cap
₹ 3,352 Cr
Current price
₹ 365.70
52-week high / low
₹ 641 / 342
Stock P/E
17.8
Book value
₹ 80.8
Dividend yield
1.09%
ROCE
35.4%
ROE
27.5%
Debt to equity
0.05
Sales growth (3 yrs)
10.2%
Profit growth (3 yrs)
28.7%
1-year return
-20.1%

About Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.

Quarterly results

Consolidated figures in ₹ crores

Mar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Sales334365372365406
Operating profit6173626180
Net profit4151414256
EPS (₹)4.475.614.474.556.09

Peers in Medical Care Facilities

Data for information only, not investment advice. Prices end of day.